Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats

European Journal of Pharmacology

Volumn 520, Issue 1-3, 2005, Pages 37-42

  Kitaichi, Yuji ^a   Inoue, Takeshi ^a   Izumi, Takeshi ^a   Nakagawa, Shin ^a   Kato, Akiko ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine; In vivo microdialysis; Milnacipran; Noradrenaline; Serotonin

Indexed keywords

DOPAMINE; MILNACIPRAN; NORADRENALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; MALE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOPROPANES; DOPAMINE; MALE; MICRODIALYSIS; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 25444443970     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.08.004     Document Type: Article

References (16)

1. M.E. Assie, M. Charveron, C. Palmier, C. Puozzo, C. Moret, and M. Briley Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat Neuropharmacology 31 1992 149 155
2. N. Bel, and F. Artigas Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran Neuropsychopharmacology 21 1999 745 754
3. J.C. Bisserbe Clinical utility of milnacipran in comparison with other antidepressants Int. Clin. Psychopharmacol. 17 suppl 1 2002 43 50
4. E. Gur, E. Dremencov, B. Lerer, and M.E. Newman Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo Eur. J. Pharmacol. 372 1999 17 24
5. 2 adrenoreceptors in the prefrontal cortex Br. J. Pharmacol. 132 2001 183 188
6. S. Kasper, Y. Pletan, A. Solles, and A. Tournoux Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results Int. Clin. Psychopharmacol. 11 suppl 4 1996 35 39
7. T. Kihara, and M. Ikeda Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex J. Pharmacol. Exp. Ther. 272 1995 177 183
8. Y. Kitaichi, T. Inoue, S. Nakagawa, T. Izumi, and T. Koyama Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats Eur. J. Pharmacol. 489 2004 187 191
9. S. Koch, S.K. Hemrick-Luecke, L.K. Thompson, D.C. Evans, P.G. Threlkeld, D.L. Nelson, K.W. Perry, and F.P. Bymaster Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats Neuropharmacology 45 2003 935 944
10. M.J. Millan, A. Gobert, F. Lejeune, A. Newman-Tancredi, J.-M. Rivet, A. Auclair, and J.-L. Peglion S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine J. Pharmacol. Exp. Ther. 298 2001 565 580
11. D. Mochizuki, R. Tsujita, S. Yamada, K. Kawasaki, Y. Otsuka, S. Hashimoto, T. Hattori, Y. Kitamura, and N. Miki Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats Psychopharmacology 162 2002 323 332
12. C. Moret, and M. Briley Effect of antidepressant drugs on monoamine synthesis in brain in vivo Neuropharmacology 31 1992 679 684
13. C. Moret, and M. Briley Effect of milnacipran and desipraminen on noradrenergic alpha2-autoreceptor sensitivity Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18 1994 1063 1072
14. M.E. Page, and I. Lucki Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex Neuropsychopharmacology 27 2002 237 247
15. O. Tajima Japanese experience with dual-action antidepressants Int. Clin. Psychopharmacol. 17 Suppl 1 2002 s37 s42
16. A.P. Van Amerongen, G. Ferrey, and A. Tournoux A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depression J. Affect. Disord. 72 2002 21 31